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Angiomyoﬁbroblastoma (AMFB) is a rare benign mesenchymal tumour that occurs almost exclusively in the vulvovaginal region
of women but can also occur occasionally in the inguinoscrotal region of men. It is a well-circumscribed lesion that clinically is
often thought to represent a Bartholin’s gland cyst and usually does not form a pedunculated mass. To our knowledge, only ﬁve
cases of vulvar AMFB with pedunculated mass have been reported in the English literature and all cases involving the labia majora
and middle-aged women. We report the ﬁrst case of pedunculated AMFB of the vulva occurring in a young woman of 21 years old
and involving the left labia minora. After excluding the most common diseases, pedunculated AMFB should be part of diﬀerential
diagnosis in the workup of any pedunculated vulvar mass even in young women with a lesion involving the labia minora. We
reviewed the literature and summarized all reported cases.
1.Introduction
Angiomyoﬁbroblastoma (AMFB) is a rare benign mesenchy-
mal tumor usually occurring in the vulvovaginal area of
middle-aged women [1–3]. Histologically, the tumor is a
well-circumscribed lesion composed of alternating hypo-
and hypercellular areas with numerous delicate capillary-
sized vessels [4]. AMFB can be distinguished from the
aggressive angiomyxoma by its circumscribed borders, the
presence of plump stromal cells, and perivascular conden-
sation of the stromal cells [5]. Immunoreactivity for both
desmin and vimentin is detected in almost all tumor cells,
which also reveal estrogen and progesterone receptors [6].
Clinically,AMFBshowsaslowlygrowingmasswhichisoften
misdiagnosed as a Bartholin’s gland cyst and usually does
not form a pedunculated mass [7]. To our knowledge, only
ﬁve cases of vulvar AMFB with pedunculated mass have been
reported in the English literature and all cases involving the
labia majora and middle-aged women [1, 7–10]. We report
the ﬁrst case of pedunculated AMFB of the vulva occurring
in a young woman of 21 years old and involving the left labia
minora.
2. Case Presentation
A 21-year-old woman came to our observation reporting the
presenceofapainlessvulvarneoformationstartingfouryears
before,whichhadgrownduringthelastmonths.Sheignored
the mass, despite its gradual enlargement during her disease
course, and the complaint was of discomfort when seated
and a localized burning sensation. Her personal history
was noncontributory for previous surgery and laboratory
data (emocrome, transaminase, sideremia, ferritin, crea-
tinine, coagulation) showed no signiﬁcant abnormalities.
Clinical examination showed a pedunculated bilobulated
neoformation of ten centimeters in diameter of tense
elastic consistency, at the level of the left labia minora
(Figure 1). On gynecological examination and vaginal ultra-
sound, the uterus and bilateral uterine adnexae showed
no abnormalities. Inguinal lymph nodes were not swollen
and tumor markers (cancer antigen (CA) 125, CA-19.9,
CA-15.3, Alphafetoprotein and carcinoembryonic antigen)
were negative. These markers were performed to exclude a
concomitant malignancy in other locations. On ultrasound
examination the mass revealed a well-demarcated soft tissue2 Case Reports in Medicine
Figure 1: The tumor shows a pedunculated large mass arising from
the labia minora with a subtle stalk.
tumor with homogeneous echo and normal vascularity.
In order to exclude a surgical disease, such as perineal
hernia [11–13], the patient was evaluated by surgeons that,
according with personal history, clinical examination, and
ultrasonography, excluded a lesion of their interest.
The mass gave a clinical impression of vulvar ﬁbroid, and
a simple tumor excision was subsequently performed at the
site of the stalk. During surgery, to exclude a malignancy
lesion, a rapid intraoperative pathologic diagnosis of the
tumor was performed, and it was reported as a benign
soft lesion of the vulva. On gross examination, the lesion
was well circumscribed, weighed 1230gr, had a soft to ﬁrm
consistency,andappearedhomogeneouslylightgraytotanin
color on the cut surface. No foci of hemorrhage nor necrosis
was detected.
Microscopically, the mass consisted of ﬁbroconnective
tissue with abundant vessels of various wall thickness (Fig-
ures 2(a) and 2(b)). No mitotic or atypical cells were seen,
and the stroma was edematous. In immunohistochemistry,
tumor cells were strongly positive for desmin and estrogen
receptors (Figures 3(a) and 3(b)) and negative for α-smooth
muscleactin,S-100 protein, cytokeratin, andCD34. Allthese
features were in favour of the diagnosis of AMFB. Surgical
margins of the lesion were clear, and the pedicle was not
involved by the tumor.
Currently the patient is in followup for two years with
clinical examination every six months with no evidence of
recurrence.
3. Discussion
This distinctive tumor was ﬁrst delineated by Fletcher et al.
in 1992 who described 10 cases involving the vulva [8]w i t h
only one case reporting a large pedunculated mass. There is
a marked predilection for the female genital tract, predomi-
nantly the vulva, although rare cases have also been reported
to arise in the scrotum and the inguinal area in males [8, 14].
The female patients have an average age of 45.8 years [5].
They usually complain of a painless mass that has been
present from a few weeks to up to 13 years [5]. Clinically,
these tumors are frequently thought to be a Bartholin gland
cyst, although a preoperative diﬀerential diagnosis includes
labial cysts, inguinal hernia, leiomyoma, and mesenchymal
tumors such as lipoma and liposarcoma [15].
On gross examination they are typically well circum-
scribed and ranged from 0.5 to 12cm. They have a soft
to rubbery consistency and a bulging, pink, and somewhat
lobulated sectioned surface [5]. Microscopic examination
conﬁrms the well-demarcated nature of the lesion and
shows alternating hypercellular and hypocellular edematous
regions with abundant blood vessels. There is minimal
nuclear atypicality, and mitotic ﬁgures are rare. The cells
tend to cluster around blood vessels, sometime forming
compact foci [5]. Adipocytes can be sparsely scattered within
the neoplasm and in rare cases fat predominates; these
tumors have been classiﬁed as the “lipomatous” variant of
angiomyoﬁbroblastoma [16]. The angiomyoﬁbroblastoma
can be distinguished from the aggressive angiomyxoma by its
circumscribed borders, the presence of plump stromal cells
that are occasionally overtly epithelioid, and perivascular
condensation of the stromal cells [17]. A single case of a
malignant transformation of an AMFB in angiomyoﬁbrosar-
coma has been reported [18]. In that tumor, areas of typ-
ical AMFB merged imperceptibly with high-grade sarcoma
resembling a myxoid malignant ﬁbrous histiocytoma.
Immunohistochemical stains show uniform staining for
vimentin and staining of a variable number of cells for
desmin in most cases. The tumor cells also show variable
expression for muscle actin and smooth muscle actin and are
frequently positive for estrogen and progesterone receptors
[5]. The expression of estrogen and progesterone receptors
suggests that it might arise as a neoplastic proliferation
of hormonally responsible mesenchymal cells [3]. Some
tumors have also stained for CD34, although some authors
question whether these CD34 positive tumors might present
ﬁbroepithelial polyps, which are frequently positive for this
marker [16].
The tumor usually exists as a sharply circumscribed
mass in the subcutaneous tissue of the vulva and usually
does not form a pedunculated mass, which represents an
exceptional event [7]. To our knowledge, only ﬁve cases of
pedunculated AMFB of the vulva have been reported in the
English literature [1, 7–10].
All cases are reported in Table 1. All patients underwent
simpleexcision.Themeanageofpatientswas46.4yearswith
a range of 41–50 years. The lesion always involved the labia
majora. The average size of the pedunculated AMFB was
of 14.2 × 13.6 centimeters in diameter (range 4 to 23cm).
Except for one case, the presence of the lesion had existed
for several years. The real problem is the preoperative clinical
diagnosis, as the vulvar AMFB is a rare event revealed only
by histological examination after surgery. All patients had an
uneventful postoperative course, and the mean followup was
of 20 months (ranging from 8 months to 3 years) with no
recurrence.
Table 2 shows immunohistochemical staining for the
most common antibodies in the AMFB. Almost all tumor
cells were strongly positive for vimentin and desmin, but
uniformly negative for cytokeratin and S-100 protein. Not
a l lt u m o rc e l l sw e r en e g a t i v ef o rα-smooth muscle actin and
CD34. Staining for estrogen and progesterone receptors was
observed in the nucleus of all tumor cells.Case Reports in Medicine 3
(a) (b)
Figure 2: (a) Photomicrograph (hematoxylin-eosin, original magniﬁcation ×2) showing pedunculated lesion covered with skin. Note the
proliferation of mesenchymal cells in richly vascularized ﬁbrous stroma. (b) Photomicrograph (hematoxylin-eosin, original magniﬁcation
×10) showing a mixture of hypercellular and hypocellular edematous areas with abundant small- to medium-sized vessels.
(a) (b)
Figure 3: (a) Photomicrograph (immunohistochemical staining for desmin, original magniﬁcation ×10) showing desmin positivity for
mesenchymal proliferation. (b) Photomicrograph (immunohistochemical staining for estrogen receptors, original magniﬁcation ×10)
showing positivity of stromal elements for estrogen receptors.
Table 1: Clinical features of pedunculated AMFB of the vulva.
References Patient no. Age (years) Site size (cm) Duration Clinical diagnosis Outcome
Fletcher et al. [8] 1 41 Right labia majora 4 ×12 8 years Inguinal hernia No recurrence after 2 years
Hsu et al. [1] 2 45 Left labia majora 13 ×12 6 months Not speciﬁed No recurrence after 8 months
Omori et al. [7] 3 48 Left labia majora 11 ×9 7 years Lipoma No recurrence after 3 years
Barat et al. [9] 4 50 Left labia majora 20 ×15 6 years Ulcerated vulvar mass No recurrence after 8 months
Nagai et al. [10] 5 48 Right labia majora 23 ×20 3 years Not speciﬁed No recurrence after 2 years
Table 2: Immunohistochemical staining for the most common antibodies in the AMFB.
Patient no. Desmin Vimentin e-R p-R S-100p CD34 ASMA Cytokeratin
1+ + U U − U −−
2+ U + + −−± U
3 ± ++ + − + ±−
4+ + + + − UU −
5+ + + + −−− U
+ =positive; − =negative; ± =lowpositive;U =unchecked;e-R =estrogenreceptor;p-R =progesteronereceptor;S-100p =S-100protein;ASMA =α-smooth
muscle actin.4 Case Reports in Medicine
Given the data reported in the literature on the pedun-
culated AMFB of the vulva, our case is the ﬁrst concerning
a young woman of 21 years old and involving the labia
minora. The patient underwent simple excision with clear
margin of the lesion and currently is in followup performing
clinical examination every six months for two years with no
recurrence.
This paper aims to emphasize that, after excluding the
most common vulvar diseases, the appearance of a pedun-
culated AMFB should be part of diﬀerential diagnosis in
the workup of any pedunculated vulvar mass even in young
women with a lesion involving the labia minora. The treat-
ment of choice is a surgical excision with clear margins,
which is resolutive as demonstrated by reported cases in the
literature.
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